Short Term Fellowship

 

EFIS and Immunology Letters (IL) award short-term fellowships for up to 3 months of support for purposes of transnational scientific collaboration or advanced training in techniques or methodologies. The EFIS-IL Short-term Fellowship allowance is € 1.750/month and is awarded directly to the fellowship holder. In addition, EFIS will reimburse travel costs up to € 500. Eligibility criteria follow below.

 

Congratulations to the most recent recipients of EFIS-IL Short-term Fellowships (approved February 10, 2018, Sofia)

  • Adrián Martin Esteban, from Madrid to the National Center for Scientific Research Demokritos, Athens, to work on competition for substrate binding in combination with their complementary substrate preferences may reciprocally influence ERAP1 and ERAP2 function 
  • Bianca Calì, from Padova to the Istitut Curie, to study CXCL12 signalling in the modulation of nuclear biomechanical properties of migrating neutrophils
  • Chiara Farroni, from Rome to the University of Gothenburg, Dept. of Rheumatology and Inflammation Research, to investigate altered light chain selection in autoimmunity associated to common variable immunodeficiency
  • Ivan Milenkovic, to KU Leuven from Belgrade to work on brain specific modulation of regulatory T cells in Alzheimers disease
  • Costanza Maria Cristiani, travelling from Catanzaro to the Netherlands c/o the University of Amsterdam Medical Center to study innate lymphoid cells and immunoprofile of anti PD-1 treated melanoma patients
  • Cristina Rodríguez Rojas will be visiting the Institute for Virology at the University Medical Center of the Johannes Gutenberg-University Mainz to investigate the establishment of MCMV latency in TAP-deficient mice
  • Pauline van Schouwenburg, c/o the Universitäts klinikum Freiburg Center for Chronic Immunodeficiency will tackle B-cell maturation defects in Common Variable Immunodeficiency Disorder
  • Irene Mattiola, from Berlin to the Istituto Clinico Humanitas (MI) to study innate lymphoid cells and anti-tumor immunity
  • Ana Rodríguez Galán will travel to Masaryk University, Brno, to investigate miRNA dynamics in T cell activation
  • Aleš Drobek, from Prague, will be joining the Department of Biomedicine, University Hospital Basel, for work on the tissue localization of virtual memory CD8 T cells.


Distribution of EFIS-IL Fellowships by Society and by Destination 2010 - 2017

 


 

Eligibility Criteria:

  • Applicants must be a member of an EFIS-affiliated society (exceptions to this may apply only for applicants from European countries without a national society);
  • Applicants must be 35 years of age or younger and must hold at least a Master's degree (an extension of this age limit of up to 18 months may be granted for maternity/paternity leave, civil or military service, etc.);
  • The proposed stay must be conducted in a European institution;
  • Fellowships are not awarded in order to attend courses, symposia, meetings or congresses;
  • Fellowships are not renewable and can be held only once;
  • Fellowships cannot be held simultaneously with awards or funding made available by other sources or organizations, nor can they be used to prolong visits begun under other auspices, or as a means to bridge between research visits funded by other organizations.

To apply for an EFIS-IL short-term fellowship, please provide all required information in the online application form below.

 

Documents to submit:

  • Short curriculum vitae (.doc or .pdf)
  • List of publications (.doc or .pdf)
  • Project proposal (max 2 pages, .doc or .pdf). The proposal should include summary and aim, background and operational objectives and working plan
  • Letter of recommendation (not from the receiving institute) (.doc or .pdf)
  • Acceptance letter from the head/supervisor of receiving Institute (.doc or .pdf)
  • Proof of membership in an EFIS-affiliated society (.doc or .pdf)

 

The EFIS Board evaluates applications at its periodic board meetings, held every 3-4 months.


NEXT DEADLINE TO SUBMIT YOUR APPLICATION:
November 9th, 2018